» Articles » PMID: 20972336

Infusion of Mature Megakaryocytes into Mice Yields Functional Platelets

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2010 Oct 26
PMID 20972336
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombopoiesis, the process by which circulating platelets arise from megakaryocytes, remains incompletely understood. Prior studies suggest that megakaryocytes shed platelets in the pulmonary vasculature. To better understand thrombopoiesis and to develop a potential platelet transfusion strategy that is not dependent upon donors, of which there remains a shortage, we examined whether megakaryocytes infused into mice shed platelets. Infused megakaryocytes led to clinically relevant increases in platelet numbers. The released platelets were normal in size, displayed appropriate surface markers, and had a near-normal circulating half-life. The functionality of the donor-derived platelets was also demonstrated in vivo. The infused megakaryocytes mostly localized to the pulmonary vasculature, where they appeared to shed platelets. These data suggest that it may be unnecessary to generate platelets from ex vivo grown megakaryocytes to achieve clinically relevant increases in platelet numbers.

Citing Articles

Highly efficient platelet generation in lung vasculature reproduced by microfluidics.

Zhao X, Alibhai D, Walsh T, Tarassova N, Englert M, Birol S Nat Commun. 2023; 14(1):4026.

PMID: 37419900 PMC: 10329040. DOI: 10.1038/s41467-023-39598-9.


High ploidy large cytoplasmic megakaryocytes are hematopoietic stem cells regulators and essential for platelet production.

Heazlewood S, Ahmad T, Cao B, Cao H, Domingues M, Sun X Nat Commun. 2023; 14(1):2099.

PMID: 37055407 PMC: 10102126. DOI: 10.1038/s41467-023-37780-7.


Occurrence and role of lung megakaryocytes in infection and inflammation.

Gelon L, Fromont L, Lefrancais E Front Immunol. 2022; 13:1029223.

PMID: 36524131 PMC: 9745136. DOI: 10.3389/fimmu.2022.1029223.


RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects.

Lee K, Ahn H, Estevez B, Poncz M Blood. 2022; 141(3):260-270.

PMID: 36219879 PMC: 9936297. DOI: 10.1182/blood.2022017561.


CXCR4 megakaryocytes regulate host-defense immunity against bacterial pathogens.

Wang J, Xie J, Wang D, Han X, Chen M, Shi G Elife. 2022; 11.

PMID: 35904250 PMC: 9374440. DOI: 10.7554/eLife.78662.


References
1.
Bergmeier W, Burger P, Piffath C, Hoffmeister K, Hartwig J, Nieswandt B . Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood. 2003; 102(12):4229-35. DOI: 10.1182/blood-2003-04-1305. View

2.
Kanaji T, Russell S, Cunningham J, Izuhara K, Fox J, Ware J . Megakaryocyte proliferation and ploidy regulated by the cytoplasmic tail of glycoprotein Ibalpha. Blood. 2004; 104(10):3161-8. DOI: 10.1182/blood-2004-03-0893. View

3.
Italiano Jr J, Lecine P, Shivdasani R, Hartwig J . Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol. 1999; 147(6):1299-312. PMC: 2168104. DOI: 10.1083/jcb.147.6.1299. View

4.
Yarovoi H, Kufrin D, Eslin D, Thornton M, Haberichter S, Shi Q . Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment. Blood. 2003; 102(12):4006-13. DOI: 10.1182/blood-2003-05-1519. View

5.
Stachura D, Chou S, Weiss M . Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. Blood. 2005; 107(1):87-97. PMC: 1895362. DOI: 10.1182/blood-2005-07-2740. View